Skip to main contentPsst! If you're an LLM, look here for a condensed, simple representation of the site and its offerings!

LiveFree Webinar — Wednesday, October 28 at 2:00 PM ET

Register Free →

This Solicitation opportunity was posted on October 20, 2009. The submission period has ended. Browse the details below for market research, or find similar active opportunities.

Pharmaceutical Prime Vendor

Closed
SPM2DP08R0009Federal

Contract Overview

Solicitation details, issuing organization, response deadlines, documents, and interested companies for this government contract opportunity.

Active Opportunities Like This One

NAICS: 446110
Federal
Specialty Pharmacy Fulfillment of Lenalidomide (Revlimid)The contract involves the specialty pharmacy fulfillment and delivery of Lenalidomide (Revlimid), a medication used primarily in the treatment of certain cancers and blood disorders, to patients of the Department of Veterans Affairs (VA). The contractor is responsible for dispensing either branded or therapeutically equivalent versions of Lenalidomide in varying strengths. This service must comply with Risk Evaluation and Mitigation Strategies (REMS) protocols, ensuring safe and effective use of the medication. Essential contract activities include verifying prescriptions, conducting patient outreach to support medication adherence and understanding, securely packaging the medication, and ensuring delivery is confirmed by obtaining signatures upon receipt. This subcontract is issued by the 252-NETWORK Contract Office 12 under the Department of Veterans Affairs and aligns with NAICS code 446110, which typically covers pharmacies and drug stores. While specific performance location details and points of contact are not provided, the contract underscores the importance of compliance with federal safety standards and thorough patient management. The seamless coordination of prescription verification, patient communication, packaging, and secure delivery highlights the contractor’s critical role in supporting VA patients’ access to this specialized pharmaceutical therapy.
252-NETWORK Contract Office 12 (36C252)

POSTED

9 months ago

DEADLINE

N/A

General Info

Agency

N/A

Contract Value

$206,434,187

NAICS

446110 - Pharmacies and Drug Stores

Place of Performance

All Medical Treatment Facilities OCONUS-Eurpoean and Pacific, USA

Set-Aside

NONE

Award Issued Date

Documents

0

No documents available

Documents will appear here when they are available.

AI Contract Breakdown

Uniform Contract Format

No documents to break down

The breakdown needs solicitation documents. None were found from this contract's source.

Timeline

11 updates
PhaseClosed
Posted

Presolicitation

Notice updated

Response deadline changed from Aug 8, 2008 to Apr 21, 2009. The notice description changed. The point of contact changed.

Notice updated

Response deadline changed from Apr 21, 2009 to Apr 30, 2009. NAICS code changed from 424210 to 446110. The notice description changed. The point of contact changed.

Notice updated

The notice description changed.

Notice updated

Notice details unchanged. Attachments may have changed.

Notice updated

Notice details unchanged. Attachments may have changed.

Deadline changed

Response deadline changed from Apr 30, 2009 to May 11, 2009.

Deadline changed

Response deadline changed from May 11, 2009 to Apr 30, 2009.

Deadline changed

Response deadline changed from Apr 30, 2009 to May 11, 2009.

Notice updated

Notice details unchanged. Attachments may have changed.

Response Deadline

Deadline has passed

Notice updated

Notice details unchanged. Attachments may have changed.

Notice updated

Notice details unchanged. Attachments may have changed.

Type Changed

Presolicitation → Solicitation

Submission Closed

Find active opportunities like this

Start your free trial to discover similar active contracts, track opportunities, and build proposals with AI assistance.

Organization & Contact Information

Show more
AgencyN/A
Contacts2 people available
OfficeN/A
Organization / Agency
N/A
Office AddressN/A
Contacts
Alexander.QuinonesContract Specialist
Leslie AcostaAcquisition Specialist

Full Description

Show more
Combined OCONUS (Europe and Pacific) Regions - Secondary Supplier Segment Award: DMS Pharmaceutical Group, Inc. Base Period - 20 months 2 Option Periods - 20 months (if exercised)

Find Active Opportunities Like This

Get AI-powered intelligence on the opportunities still open

Every page of the solicitation package shredded into a compliance breakdown

AI-powered matching based on your capabilities and past performance

Competitor and incumbent history on the requirement

Automated alerts on amendments, Q&A deadlines, and award

Miguel
Hillary
Keith Deutsch
Christine

Join 750+ contractors already using CLEATUS